By Sara Freeman, medwireNews Reporter mewireNews: Shortening the time that patients with advanced renal cell carcinoma are on and off treatment with sunitinib improves the drug’s overall tolerability without affecting its efficacy, ...
Tags: ORR, Tolerability, PFS, Sunitinib
Data published in New England Journal of Medicine show treatment prolongs life for women with most common cancer in under 35s New data showing cancer treatment Avastin® (bevacizumab) can extend the lives of women with advanced ...
Tags: Cervical Cancer, Avastin, GOG240, GOG
Every week reporter Ankita Rao selects interesting reading from around the Web. The New York Times: Doctors Train To Spot Signs Of A.D.H.D. In Children Jerry, 9 years old, dissolved into his Game Boy while his father described his ...
Tags: Doctor Training, Obamacare, A.D.H.D, Epilepsy
The AstraZeneca HealthCare Foundation's Connections for Cardiovascular HealthSM program today announced it will award nearly $3.7 million in grants to 19 nonprofit organizations dedicated to improving cardiovascular health in local ...
Tags: Astrazeneca, Healthcare Foundation, Cardiovascular Health, heart health
Urinary incontinence affects up to 13% of Australian men and up to 37% of Australian women. There are several types of urinary incontinence, and each has different treatment options. In the latest edition of Australian Prescriber, Shannon ...
Tags: Incontinence, Treatment Option, reducing symptom, bladder
DaVita, the kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, announced that its teammates donated $1.2 million to charities in more than 1,100 communities across the United ...
Tags: DaVita, DaVita Way of Giving, Typhoon Haiyan, American Red Cross
The good news: More people survive stroke now than 10 years ago due to improved treatment and prevention. The bad news: Women who survive stroke have a worse quality of life than men, according to a study published in the Feb. 7 online ...
A new international multi-center study led by researchers from UCSF Benioff Children's Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy that do not respond to ...
Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. ...
Tags: Prostate Cancer Cells, reawakened, preventing the spread of disease
Children and adolescents with peanut allergies could benefit from treatment with oral immunotherapy (OIT), in which peanut protein is consumed in increasingly larger amounts on a regular basis to build up tolerance, according to a phase 2 ...
Tags: Peanut Allergies, peanut protein, mild with oral itching
Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
Article cites potential to save money on end-of-life care, medical imaging and new drug prices In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue ...
A new international multi-center study led by researchers from UCSF Benioff Children's Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy that do not respond to ...
There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers returning from war zones with brain injuries, athletes with sports-related head injuries, and the growing population with age-related ...
New peanut allergy therapy shows 84 per cent success A new therapy for peanut allergy has been successful in the majority of the 99 children who took part in a trial conducted by researchers at Addenbrooke's Hospital in Cambridge, UK. ...
Tags: Peanut, allergy, peanut immunotherapy, enzyme